Author

Yi Liu

ORCID 0000-0002-2303-6212Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Yi Liu8 papers · Jilin University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:comparative / phylogenetic analysis· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Organism:human· 1 Assay:imaging· 1

Frequent Co-Authors

Aimilia VareliiD· 1 shared Alexander HoffmanniD· 1 shared Andrea G. S. PepperiD· 1 shared Chris J. PepperiD· 1 shared Eleanor S. JayawantiD· 1 shared Emma KennedyiD· 1 shared Fabio A. SimoesiD· 1 shared Haripriya Vaidehi NarayananiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aimilia VareliORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCell Death and DiseasePeer-reviewedAug 16, 2025

Systems biology-enabled targeting of NF-κB and BCL2 overcomes microenvironment-mediated BH3-mimetic resistance in DLBCL.

Aimilia Vareli, Haripriya Vaidehi Narayanan, Heather Clark…·Simon A. Mitchell

This study identifies resistance mechanisms to BH3-mimetics in DLBCL and shows that combining BCL2 inhibition with non-canonical NF-κB inhibition overcomes microenvironment-mediated resistance.

7 citations

humanflow cytometry

𝕏 PostBluesky